Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28475566 | 0.69 | CTSD (0.31) | CTSD | |
| SCHEMBL1098181 | 0.67 | CTSD (0.31) | CTSD | |
| SCHEMBL1098082 | 0.67 | CTSD (0.31) | CTSD | |
| SCHEMBL2230540 | 0.64 | CTSD (0.43) | CTSD | |
| SCHEMBL1096894 | 0.64 | — | — | |
| Acetaldehyde SCHEMBL10325496 | 0.59 | CTSD (0.32) | CTSD | |
| SCHEMBL1098899 | 0.59 | CTSD (0.32) | CTSD | |
| Formaldehyde SCHEMBL14763512 | 0.59 | CTSD (0.41) | CTSD | |
| SCHEMBL27687875 | 0.59 | CTSD (0.36) | CTSD | |
| Carbon Monoxide SCHEMBL515028 | 0.59 | CTSD (0.36) | CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153831-B2 | Group 5 metal or a Group 6 metal complexed to anionic 6 electron donor ligand, an anionic 2 electron donor ligand, a cationic 2 electron donor ligand, or neutral 2 electron donor ligand; depositing a metal and/or metal carbide/nitride layer; liner or barrier layer for conducting metals | PRAXAIR TECHNOLOGY, INC. (US) | 2012-04-10 | — | — | US | claimed |
| EP-2069373-A1 | ORGANOMETALLIC PRECURSOR COMPOUNDS | PRAXAIR TECHNOLOGY, INC. (US) | 2009-06-17 | — | — | EP | claimed |
| WO-2008039916-A1 | ORGANOMETALLIC PRECURSOR COMPOUNDS | PRAXAIR TECHNOLOGY, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| US-20080081127-A1 | Organometallic compounds, processes for the preparation thereof and methods of use thereof | PRAXAIR TECHNOLOGY, INC. | 2008-04-03 | — | — | US | claimed |
| US-8153831-B2 | Group 5 metal or a Group 6 metal complexed to anionic 6 electron donor ligand, an anionic 2 electron donor ligand, a cationic 2 electron donor ligand, or neutral 2 electron donor ligand; depositing a metal and/or metal carbide/nitride layer; liner or barrier layer for conducting metals | PRAXAIR TECHNOLOGY, INC. (US) | 2012-04-10 | — | — | US | disclosed |
| US-20080081127-A1 | Organometallic compounds, processes for the preparation thereof and methods of use thereof | PRAXAIR TECHNOLOGY, INC. | 2008-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081127-A1 | Organometallic compounds, processes for the preparation thereof and methods of use thereof | SOD1, VCAM1, C9 | CTSD 4448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.